Integrated Causal Intelligence

Causal Intelligence Drug Development

Turning complex, fragmented scientific and regulatory evidence into computable, context-aware models — across the entire R&D lifecycle.

Our Approach

From Fragmented Evidence to Computable Causal Models

At Aveiaa, we build integrated causal intelligence systems that turn complex, fragmented scientific and regulatory evidence into computable, context-aware models. Instead of treating drug development as pattern matching, we represent how outcomes emerge through mechanisms across:

  • Structure → PK → Target Engagement
  • Pathway Biology → Clinical Outcomes
  • Development Decisions at every stage
  • Regulatory-aware outputs with auditable evidence trails

Our systems support earlier risk detection, clearer rationale, and faster iteration across the entire R&D lifecycle.

Causal Intelligence
Our Philosophy

Our Technology Philosophy

Mechanistic Reasoning

Drug development is governed by biological mechanisms and pharmacology — not just correlations. We model why outcomes occur.

Regulatory Awareness

Our AI embeds regulatory constraints into every model, producing outputs aligned with development and compliance requirements.

Computable & Reviewable

Conclusions are not black boxes. Every output is auditable, with traceable evidence trails reviewable by scientists and regulators.

Context-Adaptive AI

Unlike pattern matching, our agentic systems understand context changes — so predictions remain reliable when conditions shift.

Core Architecture

Causal Mechanistic Discovery Network System (CMDNS)™

CMDNS is Aveiaa's multi-layer reasoning architecture designed to capture the true complexity of biomedical innovation. It converts complex, fragmented data into integrated mathematical and probabilistic models capable of predicting key development outcomes.

  • Integrates fundamental structure, PK, PD/Biology, and outcome layers
  • Connects to Aveiaa's Knowledge Intelligence Vault™
  • Produces high-quality normalized, structured, and computable metrics
  • Reliable evaluation across chemistry, biology, translational, and clinical dimensions

CMDNS connects multiple development layers to make reliable evaluation for chemistry, biology, translational and clinical metrics.

CMDNS Architecture
Powering Every Decision

Knowledge Intelligence Vault™

The Knowledge Intelligence Vault combines multi-interoperable atlases that power our domain engines — deployable via APIs for enterprise use.

Disease Atlas

Comprehensive structured knowledge across disease mechanisms, pathways, and phenotypic classifications for causal modeling.

Chemistry Atlas

Molecular structure representations, property profiles, and pharmacokinetic data mapped for cross-domain reasoning.

Translational Atlas

Bridging preclinical and clinical evidence to improve the predictive validity of translational decisions in drug development.

Clinical & Development Atlas

Regulatory frameworks, trial outcomes, and development constraints integrated for compliant decision support at scale.